Diabetes decisions — 2025

The Board granted service connection for diabetes mellitus type II, finding a direct relationship to the Veteran's military service.

The Board remands the claims for service connection for diabetes mellitus and bilateral lower extremity diabetic neuropathy due to an inadequate VA opinion.

The Board finds that the Veteran requires personal care services for a minimum of six continuous months based on a need for supervision, protection, or instruction due to his functional limitations caused by multiple diagnosed conditions.

The Board denied service connection for a lumbar disability and denied increased ratings for various disabilities, except for granting a 60 percent rating for coronary artery disease and a 50 percent rating for PTSD.

The Board remands the claims for service connection for diabetes mellitus type II and peripheral neuropathy of all extremities due to a need for an etiology opinion under the PACT Act.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on the need for regular aid and attendance of another, as his service-connected disabilities do not render him so helpless as to require such assistance.

The Board denied service connection for bilateral hearing loss, a dental disability to include missing teeth, and a recurrent gum disability. The claims for Type II diabetes mellitus, recurrent fatigue, lumbosacral spine, left lower extremity, ankle neurological, foot, joint, and bone disabilities were remanded.

The Board granted an evaluation of 70 percent for posttraumatic stress disorder (PTSD) with sleep disturbances and unspecified depressive disorder, but remanded the claims for service connection for diabetes mellitus, type II, eye disability, to include decreased vision, and hypertension.

The Board denied service connection for diabetes mellitus, finding no evidence of a direct link to the Veteran's service or to his service-connected Parkinson's Disease.

The Board remands the issues of ratings in excess of 60 percent for diabetes mellitus, type II, from April 8, 2024; in excess of 20 percent for diabetes mellitus, type II, from October 17, 2013, to April 8, 2024; and special monthly compensation (SMC) under 38 U.S.C. � 1114(s), based upon housebound status prior to October 17, 2013.

The Board granted earlier effective dates and service connection for tinnitus, type 2 diabetes mellitus, hypertension, and an initial rating of 30 percent for GERD.

The Board remands the Veteran's claim for service connection for diabetes, to include as secondary to OSA, lumbar retrolisthesis, left knee disabilities, or bilateral ankle disabilities, with obesity as an intermediate step, due to inadequate VA opinions and alternative theories of entitlement.

The Board denied the Veteran's appeal for a rating in excess of 20 percent for service-connected diabetes mellitus, as the evidence did not show that his condition required regulation of activities.

The Board remands the claims for service connection due to outstanding records of private treatment and a lack of VA medical opinions.

The appeal for service connection and increased ratings for various conditions, including diabetes, erectile dysfunction, bilateral shoulder disability, hemorrhoids, and knee and ankle disabilities, was dismissed.

The Veteran's service connection for PTSD was granted, while other claims were remanded for further evidence.

The Board denied the veteran's claims for increased ratings and service connection, as well as dismissed his appeals due to untimeliness of his VA Form 10182.

The Board remands the claims for service connection for ischemic heart disease and type II diabetes mellitus due to insufficient development of evidence regarding potential exposure to toxins other than herbicides.

The Board remands the claims for service connection for stroke, hypertension, diabetes mellitus, type II, and heart disease as secondary to service-connected disabilities due to duty-to-assist errors.

The Board denied service connection for diabetes, gout, lower back disability, and sleep apnea. The initial ratings for hearing loss and tinnitus were also denied.